Bonesupport
-
Biologics
BoneSupport Launches Next Generation of Cerament® G
6-30-2023 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces the launch of the…
Read More » -
Biologics
BoneSupport’s CERAMENT®G Used In First U.S. Patient Cases
10-24-2022 BONESUPPORT, an emerging leader in orthobiologics for the management of bone injuries, today announces that the company’s antibiotic-eluting bone…
Read More » -
Biologics
BONESUPPORT signs distribution agreement with OrthoPediatrics
January 13, 2022 Lund, Sweden, 15:30 CET, 22-01-13 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone…
Read More » -
Biologics
BONESUPPORT Appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America
LUND, Sweden, April 29, 2020 /PRNewswire/ — BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change…
Read More » -
Biologics
BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical longterm study
Lund, Sweden, 15.00 CET, 14 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries,…
Read More » -
Biologics
CERAMENT® – Now available exclusively through BONESUPPORT
Boston, US, 09.30 ET, 21 May 2019 – BONESUPPORT™ , an emerging leader in orthobiologics for the management of bone voids, is now…
Read More » -
Biologics
BONESUPPORT™ – Positive Results From The CERTiFy Study Comparing Cerament®|Bone Void Filler With Autograft
Lund, Sweden, 08.00 CET, 19 November 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, today announces positive top-line data…
Read More » -
Biologics
BONESUPPORT starts selling CERAMENT® BONE VOID FILLER Direct in the US via its own New Distributor Network
Lund, Sweden, 08:00 CET, 22 October 2018 –BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, announces…
Read More » -
Biologics
BONESUPPORT – CERAMENT® G Approved by Health Canada
Lund, Sweden, 18:00 CET, 16 August 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids,…
Read More » -
Biologics
BONESUPPORT Signs Agreement with MTF Biologics to Expand US Product Offering
Lund, Sweden, 08:00am CET, 2 August 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids,…
Read More » -
Biologics
BONESUPPORT Signs Strategic Agreement with Collagen Matrix, Inc. to Expand Product Offering in the US
Lund, Sweden, 13.00 CET, 24 May 2018 – BONESUPPORT, announces an agreement with Collagen Matrix, Inc. that will allow it to expand…
Read More » -
Biologics
BONESUPPORT creates its own US Commercial Platform
Lund, Sweden, 08.45 CET, 17 May 2018 – BONESUPPORT HOLDING AB (publ) announces today that the current distribution agreement has…
Read More » -
Biologics
BONESUPPORT™ Signs Commercialization Agreement for the Italian Market
Lund, Sweden, 08.00 CET, 20 November 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone…
Read More » -
Recon
BONESUPPORT™ – First Patient Recruited in Study Evaluating CERAMENT® G and CERAMENT® V in Patients Undergoing Hip and Knee Arthroplasty Revisions
Lund, Sweden, 08:00 CEST 9 October 2017 – BONESUPPORT™ an emerging leader in innovative injectable bio-ceramic bone substitute products to…
Read More » -
Biologics
BONESUPPORT™ Data Presented at EORS Highlights Cerament® Bone Void Filler’s Ability to Elute Drugs With Potential to Enhance Bone Growth
20-Sep-2017 Lund, Sweden, 08.00 CEST, 20 September 2017 – BONESUPPORT an emerging leader in innovative injectable bio-ceramic bone substitute products…
Read More »